The Patent Finder

Xilio Development, Inc.

8 patents currently held · Updated Nov 20, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Xilio Therapeutics (to 2020)

0
Ending by 2030
Sep 2039
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Masked INTERLEUKIN-12 Polypeptides (US 11,718,655) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 2 fees due May 28, 2027
  • 1 fee due Jul 9, 2027
    The maintenance fee for Masked IL-2-Fc fusion polypeptides (US 11,866,476) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,053,294Masked Cytokine Polypeptides
In force
 · Medium confidence
In forceMedium confidence
US 11,718,655Masked INTERLEUKIN-12 Polypeptides
In force
 · High confidence
In forceHigh confidence
US 11,866,476Masked IL-2-Fc fusion polypeptides
In force
 · High confidence
In forceHigh confidence
US 11,827,686Masked Cytokine Polypeptides
In force
 · Medium confidence
In forceMedium confidence
US 11,827,685Masked Cytokine Polypeptides
In force
 · Medium confidence
In forceMedium confidence
US 12,280,120Tumor-Specific Cleavable Linkers
In force
 · High confidence
In forceHigh confidence
US 12,435,142ANTI-CTLA4 Antibodies and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 12,662,520Masked IL-2 Cytokines and Methods of Use Thereof
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 8: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 6 abandoned

Showing 1 to 10 of 13, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
19/096,161Activatable Masked ANTI-CTLA4 Binding ProteinsMar 31, 2025Pending
19/016,709Masked IL-2 Cytokines and Methods of Use ThereofJan 10, 2025Pending
18/821,234Masked IL-2 Cytokines and Methods of Use ThereofAug 30, 2024Pending
18/819,975VHH Masked Cytokines and Methods of Use ThereofAug 29, 2024Pending
18/352,762Engineered Cleavable Carriers and Methods of Use ThereofJul 14, 2023Pending
18/115,527Targeted Cytokines and Methods of Use ThereofFeb 28, 2023Pending
17/932,057Cleavable LinkersSep 14, 2022Abandoned
17/684,232Combination of Masked CTLA4 and PD1/PDL1 Antibodies for Treating CancerMar 1, 2022Abandoned
17/684,211Combination of CTLA4 and PD1/PDL1 Antibodies for Treating CancerMar 1, 2022Abandoned
17/995,163Masked IL-2 Cytokines and Their Cleavage ProductsMar 31, 2021Abandoned
10 of 13 applications shown.
Pro members see all 13 published applications.
Pro members: see all 13 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited